Cat. No. 5068
Chemical Name: 4-[1,1'-Biphenyl]-4-yl-1,4,5,6,7,8-h
Biological ActivitySelective inhibitor of TGF-β signaling (IC50 = 0.85 μM); displays little or no inhibition of activin, Wnt or BMP signaling pathways. Induces proteasomal degradation of the TGF-β type II receptor. Inhibits TGF-β-induced mesoderm formation from mouse embryonic stem cells (ESCs) during early differentiation; selectively promotes the differentiation of ESCs to cardiomyocytes in vitro between days 3-5. Does not induce differentiation of vascular smooth muscle cells or endothelial cells.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Kinney et al (2013) Emerging strategies for spatiotemporal control of stem cell fate and morphogenesis. Trends Biotechnol. 31 78. PMID: 23219200.
Willems et al (2012) Small molecule-mediated TGF-ß type II receptor degradation promotes cardiomyogenesis in embryonic stem cells. Cell Stem Cell 11 242. PMID: 22862949.
If you know of a relevant reference for ITD 1 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses ITD 1 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: ITD 1, supplier, ITD1, selective, tgf-beta, tgf-b, tgf-β, signaling, pathway, inhibitors, inhibits, embryonic, stem, cells, cardiogenesis, cardiomyocytes, Tocris Bioscience, TGF-β Receptor products
Find multiple products by catalog number
New Products in this Area
Potent and selective inhibitor of TGF-βRILDN 214117
Potent and selective ALK2 inhibitorLDN 212854
Potent bone morphogenetic protein type I (ALK) inhibitor
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.